as on
| Source : NSE
as on August 14, 2025 at 4:01 PM IST
Day's Low
Day's High
0.88%
Downside
0.33%
Upside
52 Week's Low
52 Week's High
25.00%
Downside
69.56%
Upside
Market Stats | |
Previous Close | ₹233.77 |
Open | ₹234.00 |
Volume | 19.29K |
Upper Circuit | ₹280.52 |
Lower Circuit | ₹187.01 |
Day's Low | ₹232.66 |
Day's High | ₹235.5 |
52 Week Low | ₹176.05 |
52 Week High | ₹398 |
Returns % | |
1 Month Return | -4.31 % |
3 Month Return | -9.49 % |
1 Year Return | -19.81 % |
3 Year Return | + 187.47 % |
5 Year Return | + 149.57 % |
Check Sms Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹2,080.84 Cr
Return on Equity (ROE)
9.28
PE Ratio (TTM)
27.52
Return on capital employed (ROCE)
11.22
Industry PE ratio
43.28
Beta (LTM)
1.32
P/B Ratio
2.78
Dividend Yield
0.22
PEG Ratio
15.37
Quarterly Earnings Growth YOY
14.29
EPS (TTM)
5.81
Sector
Pharmaceuticals
Book Value
59.98
Technical Analysis
Bearish
View Technical Analysis
Track how Sms Pharma P/E has moved over time to understand its valuation trends.
Sms Pharma in the last 5 years
Lowest (-163.97x)
June 20, 2023
Today (27.52x)
August 14, 2025
Industry (43.28x)
August 14, 2025
Highest (2093.00x)
November 11, 2022
Today’s Price to Earnings Ratio: 27.52x
Get the annual and quarterly financial summary of SMS Pharmaceuticals Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Sms Pharma.
SMS Pharmaceuticals Ltd’s net profit jumped 24.33% since last year same period to ₹20.49Cr in the Q1 2025-2026. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated 0.84% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, SMS Pharmaceuticals Ltd has declared dividend of ₹0.40 per share on 29 May 2024 - translating a dividend yield of 0.17%.
Read More about DividendsCheck stock indices that include Sms Pharma.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sms Pharma.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 66.26% | 0.00 | |
Foreign Institutions | 0.03% | ||
Mutual Funds | 3.03% | 24.78 | |
Retail Investors | 30.67% | ||
Others | 0% |
Compare market cap, revenue, PE, and other key metrics of Sms Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 2,080.84 | 29.91% | 0.67 | 49 | 709 | |
NA | 138.38 | -10.52% | 0.00 | 12 | 69 | |
NA | 48.85 | -16.67% | 0.00 | -22 | 104 | |
NA | 48.17 | 105.43% | 0.00 | -1 | NA | |
NA | 496.33 | 21.03% | 0.00 | NA | NA |
Latest news and events in one place to help you make informed investing decisions in Sms Pharma.
SMS Pharmaceuticals Achieves Clean USFDA Inspection - 25 Jun, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, SMSPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
MF Holding Up
Mutual Funds have increased holdings from 2.43% to 3.03% in Jun 2025 quarter
Profit Spike
Netprofit is up for the last 4 quarters, 14.1 Cr → 20.49 Cr (in ₹), with an average increase of 11.3% per quarter
Price Rise
In the last 7 days, SMSPHARMA stock has moved up by 2.2%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 66.26% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 32.3% return, outperforming this stock by 52.1%
Revenue Fall
Revenue is down for the last 2 quarters, 249.62 Cr → 196.64 Cr (in ₹), with an average decrease of 21.2% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 31.22% to 30.67% in Jun 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 0.08% to 0.03% in Jun 2025 quarter
Organisation | SMS Pharmaceuticals Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
CEO | P Ramesh Babu |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Sms Pharma.
Funds | Holdings | Prev. 5M |
---|---|---|
Quant Small Cap Fund Growth Option Direct Plan | 0.15% | |
Quant Healthcare Fund Direct Growth | 4.77% | |
Bandhan BSE Healthcare Index Fund Direct Growth | 0.05% |
Sms Pharma share price today stands at ₹234.72, Open: ₹234, Previous Close: ₹233.77, High: ₹235.5, Low: ₹232.66, 52 Week High: ₹398, 52 Week Low: ₹176.05 as on .
To buy Sms Pharma shares, you need to follow these steps:
Today's traded volume of Sms Pharma is 19.29K. Which means that 19.29K shares of Sms Pharma were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Sms Pharma is ₹2,080.84 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Sms Pharma’s 52 week high is ₹398 and 52 week low is ₹176.05. The current share price of Sms Pharma is ₹234.72, which is -41.03% down from its 52 week high and 33.33% up from its 52 week low.